Clinical spectrum, complications and management outcomes in paediatric dengue: a retrospective analysis
DOI:
https://doi.org/10.18203/2349-3291.ijcp20262957Keywords:
Complications, Duration of hospital stay, Dengue, Outcome, Steroid, ThrombocytopeniaAbstract
Background: The dengue fever remains a major cause of acute febrile illness among children in India. To provide region-specific data from central Maharashtra, this study evaluated the clinical spectrum, complications, outcomes and impact of steroid therapy in paediatric dengue patients.
Methods: This retrospective observational study was conducted at a tertiary care centre in Chhatrapati Sambhajinagar, Maharashtra covering the period of January 2021 to December 2025. A total of 355 children (<18 years) with serologically confirmed dengue (NS1/IgM positive) were included. Patients were classified into mild, moderate and severe dengue according to WHO guidelines. Clinical features, laboratory parameters, steroid use in context of complications, duration of hospital stay and outcomes were analysed.
Results: A total of 355 patients, 60.3% were males, with 49.0% aged 10–15 years. Mild dengue was seen in 55.8%, moderate in 38.6% and severe in 5.6% of cases. Fever was the most common symptom (98.03%), followed by abdominal pain (20.85%). Warning signs included fluid accumulation (10.70%) and mucocutaneous bleeding (9.57%). Severe manifestations such as shock (3.09%), ARDS (1.97%) and altered sensorium (1.69%) were uncommon. No cases of renal failure or major haemorrhage were observed in this cohort. Hospital stays increased with disease severity. Outcomes were favourable, with minimal mortality.
Conclusions: Paediatric dengue in this cohort was predominantly mild to moderate with low complication rates. Early diagnosis and standardized, WHO-guideline-based management contributed to favourable outcomes. The judicious use of steroids in moderate and severe cases appeared to reduce complications and improve outcomes, though its effect on hospital stay remains unclear. Thus, larger prospective studies are needed to confirm the role and timing of steroids in early dengue management.
References
National Center for Vector Borne Diseases Control. National guidelines for clinical management of dengue fever. 2023.
Dash N, Aby R, Kumar M, Abraham AM, Rose W. Infant dengue a 10-year experience from a tertiary center in South India. American J Tropical Med Hygiene. 2021;105(2):435.
Sharp TM, Anderson KB, Katzelnick LC, Clapham H, Johansson MA, Morrison AC, et al. Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation. Lancet Infect Dis. 2022;22(2):42-51.
Rajapakse S. Corticosteroids in the treatment of dengue illness. Transact Royal Soc Trop Med Hyg. 2009;103(2):122-6.
Al‐Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology. Cochrane Datab Syst Rev. 2016;4:87.
Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. New England J Med. 2012;366(15):1423-32.
Low GK, Jiee SF, Velasquez Leiva MF, Signor LD, Favour Omosumwen O. The methodological quality of dengue clinical practice guidelines globally. A systematic review. QJM: An Int J Med. 2026;2:672.
Shultana K, Rahman AZ, Al Baki A, Khan MS, Deb B, Chowdhury D, et al. Dengue infection in children: clinical profile and outcome in Dhaka City. Am J Pediatr. 2019;5(3):111.
Arankalle V, Shrivastava S, Kulkarni R, Patil R, Tiraki D, Mankar S, et al. Dengue in Pune city, India (2017–2019): a comprehensive analysis. Frontiers in Public Health. 2024;22:1354510.
Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clinical epidemiology. 2013;20:299-309.
Guzman MG, Martinez E. Central and peripheral nervous system manifestations associated with dengue illness. Viruses. 2024;16(9):1367.
Vuong NL, Manh DH, Mai NT, Phuc LH, Luong VT, Quan VD, et al. Criteria of “persistent vomiting” in the WHO 2009 warning signs for dengue case classification. Tropical medicine and health. Immune mechanisms in dengue severity. Nat Rev Immunol. 2020;4:68.
Leo YS, Gan VC, Ng EL, Hao Y, Ng LC, Pok KY, et al. Utility of warning signs in guiding admission and predicting severe disease in adult dengue. BMC Infect Dis. 2013;13(1):498.
Rodrigo C, Sigera C, Fernando D, Rajapakse S. Plasma leakage in dengue: a systematic review of prospective observational studies. BMC Infect Dis. 2021;21(1):1082.
Wang WH, Urbina AN, Chang MR, Assavalapsakul W, Lu PL, Chen YH, et al. Dengue hemorrhagic fever–A systemic literature review of current perspectives on pathogenesis, prevention and control. J Microbiol Immunol Infect. 2020;53(6):963-78.
Vikhe VB, Khandol D, Faruqi AA, Reddy A. A study on the clinical profile of patients presenting with dengue fever and the precision prediction of dengue severity using platelet count at presentation. Cureus. 2024;26;16(6):586.
Asha J, Baiju NM, Innah SJ, Rafi A, John BM. Comparison of platelet indices in dengue fever patients based on platelet transfusion: A prospective observational study in a tertiary care center. Asian J Transf Sc. 2023;17(1):21-7.
Mallhi TH, Khan AH, Adnan AS, Sarriff A, Khan YH, Jummaat F. Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis. 2015;15(1):399.
Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712-23.
Downloads
Published
How to Cite
Issue
Section
